Welcome to Rose!

Rose is primarily a group management bot, and has limited functionality in channels.

Channel features include:
- Log channels
- Fed logs
- Joining federations

📣 Been quiet here, but for good reason…

Our recent paper on Eli5a just dropped — and it’s making waves. Months in the making, this marks a milestone in our journey. Since March, we’ve added two Harvard PhDs to the team and joined forces with leading DeSci voices. TradSci × DeSci is in motion.

🇮🇹 Today, our science lead is presenting Eli5a’s latest AI pathology insights live in Italy.

What’s next?

✅ We’ve begun the CB checkmark process — authenticity matters. Given CB is launching v2, they are busy ⚡️
📖 Eli5a’s reading level now outperforms GPT & Claude in recent tests (we’re happy to share results).
🧠 It can now break down complex health topics by scanning influencer chatter on X — check our latest Long Covid post.

And yes, our next paper is already in progress. No other AI agent in DeSci has peer-reviewed papers backing its science. Eli5a is building the future — transparently, collaboratively, and openly.

Stay tuned.

Eli5a just started a LP to provide more liquidity to the market!

promised to be an engaging session

Eli5a is on its way to the top 10 endorsed agents on CB, with your help, we can get there faster!

Endorsed agents receive exclusive resources and exponential growth potential! Help our scientists disseminate scientific information to the masses

That was quick!

🚨 Eli5a Takes the Global Stage 🚨

At this year’s IADR General Session in Barcelona — the premier international forum for dental and oral health research — Eli5a’s Chief Scientific Officer was honored as the guest speaker for the AI symposium.

His talk, “AI-Powered Spatial Multi-Omics for High-Risk Oral Precancerous Lesions,” was not just another presentation — it was a signal. A signal that Eli5a is setting the pace in a space crowded with noise but starved for substance.

We weren’t just invited.
We were the only ones invited.

While others chase headlines, Eli5a is driving research that earns seats at the world’s most respected tables. This is more than validation — it’s momentum.

For investors seeking real traction in AI-driven healthcare, the signal couldn’t be clearer:
Eli5a isn’t watching the future unfold. We’re building it.

🫡 The latest from CryptoGics 🤝

Community driven

Eli5a slowly working its way to the top 10

Update from the Eli5a Science Team – We’ve begun targeting highly controversial and impactful scientific posts, particularly those that may promote misinformation. Our goal is to debunk false or misleading claims and provide the scientifically uninitiated public with clear, accurate, and easy-to-understand information.

An upcoming post will focus on a controversial new supplement that has been aggressively promoted in the mass market—despite clear disregard for its underlying carcinogenic risk profile.

Stay tuned for more updates.

Check out our last spaces session! New spaces session coming later this month:

https://x.com/andrewhemingway/status/1906753395483922792?s=46&t=uq61w-xRqKcGZZYSY5wpmQ

CreatorBid will meet Eli5a tomorrow to do the Checkmark Verification 🚀 🚀 🚀 This is the first setup to get the checkmark

Check out what the Eli5a science team has been working on, controversy has far greater reach! Finally a scientific police for the masses!

https://x.com/eli5xt/status/1940330834109612523?s=48&t=uq61w-xRqKcGZZYSY5wpmQ

Perhaps our call with CB went well????

Hello all - our paper has been accepted by another journal 🤝

Another example of how popular the paper is

https://x.com/eli5xt/status/1940730765639373195?s=46&t=PnIbyWmQKGiUPk53b_yJLQ

Something is brewing 🫡

🚨 Announcement coming in 5 📢

🚀Starting Friday, we’re shifting gears.

We are trying something new with raiders.

More content will be published and we want your support to grow our community.

Please like, engage, comment, etc on our X posts starting Friday to boost Eli5a further to more audiences 🫡